Literature DB >> 21212848

Histopathologic analysis of palpebral conjunctiva in thyroid-related orbitopathy (an american ophthalmological society thesis).

Don O Kikkawa1.   

Abstract

PURPOSE: To examine the histopathology of palpebral conjunctiva in patients with thyroid-related orbitopathy. Based on previously published anecdotes, the hypothesis is that conjunctiva shows increased inflammation and fibrosis.
METHODS: This was a comparative case series. Superior palpebral conjunctiva was examined from two groups. The study group consisted of 20 patients undergoing thyroid-related upper eyelid retraction surgery. The control group consisted of 18 patients undergoing ptosis repair. Specimens were processed and stained using hematoxylin and eosin and trichrome. Histopathologic grading was performed using light microscopy. Main outcome measures were degree of inflammation and fibrosis, mast cell infiltration, and fibroblast count.
RESULTS: The two groups did not differ with regard to age or gender. Mean degree of inflammation was 1.4 (95% CI: 0.9, 1.9) for the control group and 1.7 (95% CI: 1.3, 2.1) for the study group. Relative intensity of blue from trichrome staining mean was 134.3 (95% CI: 130.3, 138.3) for the control group and 138.6 (95% CI: 133.7, 143.6) for the study group. The Mann-Whitney test showed no difference between groups in inflammation (P=.17), relative blue intensity (P=.11), degree of mast cell infiltration (P=.61), and fibroblast count (P=.45). Point estimates show a trend toward greater inflammation in the study group.
CONCLUSIONS: While there is a trend toward higher inflammation in the study group, the superior palpebral conjunctiva of patients with thyroid-related orbitopathy is largely spared from autoimmune changes. This has implications in surgical approaches to eyelid retraction repair.

Entities:  

Mesh:

Year:  2010        PMID: 21212848      PMCID: PMC3016081     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  57 in total

Review 1.  Grave's disease 1835-2002.

Authors:  A P Weetman
Journal:  Horm Res       Date:  2003

2.  Graded full-thickness anterior blepharotomy for upper eyelid retraction.

Authors:  Victor M Elner; Adam S Hassan; Bartley R Frueh
Journal:  Trans Am Ophthalmol Soc       Date:  2003

3.  Immunoglobulins from patients with Graves' disease induce hyaluronan synthesis in their orbital fibroblasts through the self-antigen, insulin-like growth factor-I receptor.

Authors:  Terry J Smith; Neil Hoa
Journal:  J Clin Endocrinol Metab       Date:  2004-10       Impact factor: 5.958

4.  Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy.

Authors:  M P Mourits; M F Prummel; W M Wiersinga; L Koornneef
Journal:  Clin Endocrinol (Oxf)       Date:  1997-07       Impact factor: 3.478

Review 5.  The putative role of prostaglandin endoperoxide H synthase-2 in the pathogenesis of thyroid-associated orbitopathy.

Authors:  T J Smith
Journal:  Exp Clin Endocrinol Diabetes       Date:  1999       Impact factor: 2.949

6.  Clinic-cytologic study of conjunctivochalasis and its relation to thyroid autoimmune diseases: prospective cohort study.

Authors:  Sandra Flavia Fiorentini de Almeida; Luciene B de Sousa; Luis A Vieira; Maria I Chiamollera; Jeison de N Barros
Journal:  Cornea       Date:  2006-08       Impact factor: 2.651

7.  The association of cigarette smoking with clinical subtypes of ophthalmic Graves' disease.

Authors:  W R Nunery; R T Martin; G W Heinz; T J Gavin
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1993-06       Impact factor: 1.746

8.  Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection.

Authors:  Jimmy M Uddin; Peter D Davies
Journal:  Ophthalmology       Date:  2002-06       Impact factor: 12.079

9.  Apoptosis in orbital fibroadipose tissue and its association with clinical features in Graves' ophthalmopathy.

Authors:  Onur Konuk; Ahmet Hondur; Nalan Akyurek; Mehmet Unal
Journal:  Ocul Immunol Inflamm       Date:  2007 Mar-Apr       Impact factor: 3.070

Review 10.  Diagnostic criteria for Graves' ophthalmopathy.

Authors:  G B Bartley; C A Gorman
Journal:  Am J Ophthalmol       Date:  1995-06       Impact factor: 5.258

View more
  1 in total

Review 1.  Management of eyelid retraction related to thyroid eye disease.

Authors:  Tammy H Osaki; Lucas G Monteiro; Midori H Osaki
Journal:  Taiwan J Ophthalmol       Date:  2022-02-14
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.